People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nuvaira, Inc. | — | Other Health Care | Series C | $177.8M | $191.7M | 2014 |
| Anulex Technologies Inc | — | Biotechnology | Series B | $32.3M | $724.8M | 2009 |
| K Spine, Inc. | — | Other Health Care | Seed | $5.0M | $62.3M | 2010 |
Dave Stassen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dave Stassen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dave W. Stassen | 2 | 2 |
| Kirk Nielsen | 1 | 13 |
| Buzz Benson | 1 | 8 |
| Mike Sherman | 1 | 6 |
| Michael A. Carusi | 1 | 6 |
| Henry A. Plain | 1 | 5 |
| Hank Plain | 1 | 5 |
| David Stassen | 1 | 5 |
| Mark Deem | 1 | 5 |
| Timothy Miller | 1 | 4 |
| DAN SACHS | 1 | 4 |
| A. Jay Graf | 1 | 3 |
| Mike Carusi | 1 | 3 |
| Christopher A. Shen | 1 | 3 |
| DENNIS W. WAHR | 1 | 3 |
| MARK A. DEEM | 1 | 3 |
| Nancy Ness | 1 | 3 |
| Dale Spencer | 1 | 3 |
| Steven Dimmer | 1 | 2 |
| Kirk W. Nielsen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.